Targeting In Vivo Metabolic Vulnerabilities of Th2 and Th17 Cells Reduces Airway Inflammation
- 8 February 2021
- journal article
- research article
- Published by The American Association of Immunologists in The Journal of Immunology
- Vol. 206 (6), 1127-1139
- https://doi.org/10.4049/jimmunol.2001029
Abstract
T effector cells promote inflammation in asthmatic patients, and both Th2 and Th17 CD4 T cells have been implicated in severe forms of the disease. The metabolic phenotypes and dependencies of these cells, however, remain poorly understood in the regulation of airway inflammation. In this study, we show the bronchoalveolar lavage fluid of asthmatic patients had markers of elevated glucose and glutamine metabolism. Further, peripheral blood T cells of asthmatics had broadly elevated expression of metabolic proteins when analyzed by mass cytometry compared with healthy controls. Therefore, we hypothesized that glucose and glutamine metabolism promote allergic airway inflammation. We tested this hypothesis in two murine models of airway inflammation. T cells from lungs of mice sensitized with Alternaria alternata extract displayed genetic signatures for elevated oxidative and glucose metabolism by single-cell RNA sequencing. This result was most pronounced when protein levels were measured in IL-17–producing cells and was recapitulated when airway inflammation was induced with house dust mite plus LPS, a model that led to abundant IL-4– and IL-17–producing T cells. Importantly, inhibitors of the glucose transporter 1 or glutaminase in vivo attenuated house dust mite + LPS eosinophilia, T cell cytokine production, and airway hyperresponsiveness as well as augmented the immunosuppressive properties of dexamethasone. These data show that T cells induce markers to support metabolism in vivo in airway inflammation and that this correlates with inflammatory cytokine production. Targeting metabolic pathways may provide a new direction to protect from disease and enhance the effectiveness of steroid therapy.Keywords
Funding Information
- Division of Intramural Research, National Institute of Allergy and Infectious Diseases (R21AI121420)
- National Institute of Environmental Health Sciences (P30ES000267)
- Division of Cancer Epidemiology and Genetics, National Cancer Institute (F30CA239367)
This publication has 41 references indexed in Scilit:
- Corticosteroid resistance in patients with asthma and chronic obstructive pulmonary diseaseJournal of Allergy and Clinical Immunology, 2013
- Th17 responses in chronic allergic airway inflammation abrogate regulatory T-cell-mediated tolerance and contribute to airway remodelingMucosal Immunology, 2012
- clusterProfiler: an R Package for Comparing Biological Themes Among Gene ClustersOMICS: A Journal of Integrative Biology, 2012
- Natural‐source d‐α‐tocopheryl acetate inhibits oxidant stress and modulates atopic asthma in humans in vivoAllergy, 2012
- The role of low-level lactate production in airway inflammation in asthmaAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2012
- HIF1α–dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cellsThe Journal of Experimental Medicine, 2011
- Cutting Edge: Distinct Glycolytic and Lipid Oxidative Metabolic Programs Are Essential for Effector and Regulatory CD4+ T Cell SubsetsThe Journal of Immunology, 2011
- The Mammalian Target of Rapamycin: Linking T Cell Differentiation, Function, and MetabolismImmunity, 2010
- Inhibition of glycolysis modulates prednisolone resistance in acute lymphoblastic leukemia cellsBlood, 2009
- Relative Corticosteroid Insensitivity of Peripheral Blood Mononuclear Cells in Severe AsthmaAmerican Journal of Respiratory and Critical Care Medicine, 2006